The revolutionary promise of 3D biology 12–18 years + $1 . 3B = 1 drug . . . . . . . . . . . . . 5 Limitations of conventional cell models . . . 6 FDA Modernization Act 2.0 . . . . . . . . . . . . . . 7 Organoids Applications and research . . . . . . . . . . . . . . . 8 Organoidsinaction.....................9 The challenges with organoids. . . . . . . . . . . 10 Realizing a future of advanced drug discovery will require radical innovation To get there, we must . . . . . . . . . . . . . . . . . . 12 Organoid screening workflow . . . . . . . . . . . 13 Organoid Innovation Center . . . . . . . . . . . . . 14 Table of Contents
Made with FlippingBook. PDF to flipbook with ease